Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.99
+0.17 (1.73%)
Jun 10, 2026, 3:00 PM EDT - Market open
Phathom Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $28 | Buy | Maintains | $28 | +180.28% | Jun 1, 2026 |
| Barclays | Barclays | Buy Maintains $18 | Buy | Maintains | $18 | +80.18% | May 15, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $25 | Buy | Reiterates | $25 | +150.25% | May 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $26 | Buy | Reiterates | $26 | +160.26% | May 1, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Apr 30, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 28, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $28 | Buy | Maintains | $28 | +180.28% | Jan 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $29 | Buy | Maintains | $29 | +190.29% | Jan 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.